$14.72
0.04[0.27%]
At close: Apr 19
$14.72
0[0.00%]
After Hours: 4:00PM EDT
Merrimack Pharmaceuticals
(NASDAQ:MACK)Merrimack Pharmaceuticals Stock (NASDAQ:MACK), Earnings Estimates, EPS, and Revenue
Merrimack Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 7
EPS
$-0.010
Quarterly Revenue
$0K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Merrimack Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/02/2024 | PM | MACK | Q1 | -$0.02 | — | — | — | $0.00 | — | — | — | Get Alert |
| 03/07/2024 | PM | MACK | Q4 | -$0.03 | — | -$0.01 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/02/2023 | PM | MACK | Q3 | -$0.03 | — | -$0.02 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/03/2023 | PM | MACK | Q2 | -$0.04 | — | -$0.03 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/04/2023 | PM | MACK | Q1 | -$0.01 | — | -$0.02 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/09/2023 | PM | MACK | Q4 | -$0.03 | — | -$0.03 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/03/2022 | PM | MACK | Q3 | -$0.04 | — | -$0.03 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/04/2022 | PM | MACK | Q2 | -$0.06 | — | -$0.04 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/05/2022 | PM | MACK | Q1 | -$0.05 | — | -$0.01 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/09/2022 | PM | MACK | Q4 | -$0.08 | — | -$0.03 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/04/2021 | PM | MACK | Q3 | -$0.08 | — | -$0.04 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/05/2021 | PM | MACK | Q2 | -$0.09 | — | -$0.06 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/06/2021 | PM | MACK | Q1 | $0.02 | — | -$0.05 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/10/2021 | PM | MACK | Q4 | -$0.05 | — | -$0.08 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/04/2020 | PM | MACK | Q3 | -$0.21 | — | -$0.08 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/07/2020 | AM | MACK | Q2 | -$0.71 | — | -$0.09 | — | $0.00 | — | $0.00 | — | Get Alert |
| 05/07/2020 | PM | MACK | Q1 | -$0.78 | — | $0.02 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/12/2020 | AM | MACK | Q4 | -$0.97 | — | -$0.05 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/12/2019 | AM | MACK | Q3 | -$0.92 | — | -$0.21 | — | $0.00 | — | $0.00 | — | Get Alert |
FAQ
When is Merrimack Pharmaceuticals (NASDAQ:MACK) reporting earnings?
Merrimack Pharmaceuticals (MACK) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on March 7, 2024 for Q4.
What were the latest earnings per share (EPS) for Merrimack Pharmaceuticals (NASDAQ:MACK)?
The Actual EPS was $-0.01, which missed the estimate of $0.00.
What were Merrimack Pharmaceuticals’s (NASDAQ:MACK) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.